Biocon Ltd. (BIOCON) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 201791, "name": "Biocon", "stock_name": "Biocon", "full_name": "Biocon Ltd.", "name_url": "stocks-analysis/biocon", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "379.80", "chg": 11.45, "chgp": "3.11%", "dir": 1, "prev_price": "368.35", "mcapval": "61,124.00 Cr", "mcap": "Mid Cap", "scripcode": 532523, "symbol": "BIOCON", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE376G01013", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "1.23 cr", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-0&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "HT", "url": "https://www.marketsmojo.com/mojopro/strategy/1", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-0&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Biocon Ltd. Downgraded to Hold Amid Mixed Technicals and Valuation Appeal", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-downgraded-to-hold-amid-mixed-technicals-and-valuation-appeal-3895863", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BioconLtd_mojoScore_3895863.png", "date": "2026-03-17 08:16:04", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 16 March 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate strong financial performance and attractive valuation metrics, evolving technical indicators and market dynamics have prompted a more cautious stance among investors." }, { "title": "Biocon Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3892566", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BioconLtd_technicaldot_3892566.png", "date": "2026-03-16 08:00:19", "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the company’s longer-term technical outlook remains cautiously optimistic, supported by a recent upgrade in its Mojo Grade from Hold to Buy." }, { "title": "Biocon Ltd. Edges Up 0.18% Despite Mixed Technical Signals and Sector Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-edges-up-018-despite-mixed-technical-signals-and-sector-volatility-3892391", "imagepath": "", "date": "2026-03-15 15:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Stock opens at Rs.388.35 amid broad market weakness</p>\n <p><strong>4 Mar:</strong> Technical momentum shifts signal mildly bullish outlook</p>\n <p><strong>5 Mar:</strong> Downgrade to Hold rating amid mixed technicals and valuation</p>\n <p><strong>6 Mar:</strong> Week closes at Rs.390.45, up 0.18% vs Sensex down 3.00%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.388.35</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat..." }, { "title": "Biocon Ltd. Upgraded to Buy by MarketsMOJO on Strong Financial and Valuation Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-valuation-metrics-3886331", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BioconLtd_mojoScore_3886331.png", "date": "2026-03-12 08:05:49", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 11 March 2026. This upgrade reflects a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical outlook, underpinned by robust quarterly results and favourable market performance." }, { "title": "Biocon Ltd. Downgraded to Hold Amid Mixed Technicals and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-downgraded-to-hold-amid-mixed-technicals-and-valuation-signals-3872793", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BioconLtd_mojoScore_3872793.png", "date": "2026-03-05 08:09:24", "description": "Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 4 March 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technical indicators. Despite strong long-term returns and improving fundamentals, recent technical signals and valuation metrics have prompted a more cautious stance among analysts." }, { "title": "Biocon Ltd. Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3868053", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BioconLtd_technicaldot_3868053.png", "date": "2026-03-04 08:01:07", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across key indicators. With a recent upgrade in its Mojo Grade from Hold to Buy and a current Mojo Score of 74.0, the stock’s technical landscape warrants a detailed examination to understand its near-term trajectory and investment appeal." }, { "title": "Biocon Ltd Gains 1.51%: 3 Key Factors Driving the Weekly Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-gains-151-3-key-factors-driving-the-weekly-momentum-3862741", "imagepath": "", "date": "2026-02-28 17:09:48", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Stock opened at Rs.387.80 with a 1.00% gain</p>\n <p><strong>25 Feb:</strong> Significant surge in open interest and volume in derivatives</p>\n <p><strong>26 Feb:</strong> Minor price dip amid positive technical signals</p>\n <p><strong>27 Feb:</strong> Mojo Grade upgraded to Buy, technical momentum shifts bullish</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.383.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..." }, { "title": "Biocon Ltd. Upgraded to Buy by MarketsMOJO on Strong Financial and Technical Grounds", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-technical-grounds-3859593", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BioconLtd_mojoScore_3859593.png", "date": "2026-02-27 08:03:48", "description": "Biocon Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 26 February 2026, is underpinned by a comprehensive analysis of the company’s recent performance and market positioning." }, { "title": "Biocon Ltd. Technical Momentum Shifts Signal Bullish Outlook Amidst Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-signal-bullish-outlook-amidst-market-volatility-3859468", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BioconLtd_technicaldot_3859468.png", "date": "2026-02-27 08:00:13", "description": "Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest an improving price momentum despite some mixed signals on longer-term charts." } ], "total": 5786, "sid": "201791", "stock_news_url": "https://www.marketsmojo.com/news/biocon-201791" }, "announcements": [ { "caption": "Notification To Stock Exchanges", "datetime": "12-Mar-2026", "details": "Notification to Stock Exchanges", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "05-Mar-2026", "details": "Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "02-Mar-2026", "details": "Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 04 Jul 25", "dt": "2025-07-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19", "dt": "2019-06-12", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Mar: Stock opens at Rs.388.35 amid broad market weakness

4 Mar: Technical momentum shifts signal mildly bullish outlook

5 Mar: Downgrade to Hold rating amid mixed technicals and valuation

6 Mar: Week closes at Rs.390.45, up 0.18% vs Sensex down 3.00%

Week Open

Rs.388.35

Week Close

Read full news article

Biocon Ltd. Upgraded to Buy by MarketsMOJO on Strong Financial and Valuation Metrics

2026-03-12 08:05:49

Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 11 March 2026. This upgrade reflects a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical outlook, underpinned by robust quarterly results and favourable market performance.

Read full news article

Biocon Ltd. Downgraded to Hold Amid Mixed Technicals and Valuation Signals

2026-03-05 08:09:24

Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 4 March 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technical indicators. Despite strong long-term returns and improving fundamentals, recent technical signals and valuation metrics have prompted a more cautious stance among analysts.

Read full news article

Biocon Ltd. Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-03-04 08:01:07

Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across key indicators. With a recent upgrade in its Mojo Grade from Hold to Buy and a current Mojo Score of 74.0, the stock’s technical landscape warrants a detailed examination to understand its near-term trajectory and investment appeal.

Read full news article

Biocon Ltd Gains 1.51%: 3 Key Factors Driving the Weekly Momentum

2026-02-28 17:09:48

Key Events This Week

23 Feb: Stock opened at Rs.387.80 with a 1.00% gain

25 Feb: Significant surge in open interest and volume in derivatives

26 Feb: Minor price dip amid positive technical signals

27 Feb: Mojo Grade upgraded to Buy, technical momentum shifts bullish

Week Open

Rs.383.95

Week Close

Read full news article

Biocon Ltd. Upgraded to Buy by MarketsMOJO on Strong Financial and Technical Grounds

2026-02-27 08:03:48

Biocon Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 26 February 2026, is underpinned by a comprehensive analysis of the company’s recent performance and market positioning.

Read full news article

Biocon Ltd. Technical Momentum Shifts Signal Bullish Outlook Amidst Market Volatility

2026-02-27 08:00:13

Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest an improving price momentum despite some mixed signals on longer-term charts.

Read full news article

View All News